Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.
- NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_assertion description "[Together, this may suggest that two molecular pathways, intermediate methylation associated with KRAS mutations and LST-G morphology, and low methylation associated with CTNNB1 activation and LST-NG morphology, might be involved in LST development, and that involvement of TP53 mutations could be important in both subtypes in the development from adenoma to cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.
- NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_assertion evidence source_evidence_literature NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.
- NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_assertion SIO_000772 24590867 NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.
- NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_assertion wasDerivedFrom befree-2016 NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.
- NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_assertion wasGeneratedBy ECO_0000203 NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1160040.RAso7Wjk-dZCxxPt_DUELoa4Jd0r50-EguTuvWI1sCPU4130_provenance.